GPCR Q4 2025 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$24M

Net Income

$33M

EPS (Diluted)

$0.60

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$66M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$68M

Stockholders' Equity

$1.5B

Cash & Equivalents

$800M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	$24M	-$47M	+151.0%
Net Income	$33M	-$36M	+190.5%